Per consulting firm Leverage, 15 states provide coverage to their employees. Illinois has added coverage of the drugs for state employees as of July 1.
GLP-1 drugs approved for weight loss, including Wegovy, Saxenda and Zepbound, can cost over $10,000 a year. Some employers have stopped covering the drugs for employees because of their cost.
In January, North Carolina officials said the state would no longer cover the drug for employees, citing high costs.
Here are 16 states currently covering GLP-1 drugs for weight loss:
- Alaska
- Connecticut
- Delaware
- Georgia
- Idaho
- Illinois
- Indiana
- Kansas
- Kentucky
- Massachusetts
- Michigan
- New Jersey
- New Mexico
- New York
- Tennessee
- Wyoming
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 17–19 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
